JORGE VIERA: Open Payments
NPI 1780038356 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,279 in 59 payments from 20 companies in 2025. Trend: 2023 $990 · 2024 $1,320 · 2025 $1,279
Food & beverage: $1,265Education: $15
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $351 |
| Braeburn Inc. | 6 | $203 |
| Lilly USA, LLC | 12 | $140 |
| Alkermes, Inc. | 4 | $80 |
| Xeris Pharmaceuticals, Inc. | 4 | $65 |
| Exact Sciences Corporation | 2 | $59 |
| Corcept Therapeutics | 2 | $49 |
| Ardelyx, Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Amphastar Pharmaceuticals, Inc. | 2 | $35 |
Products named: BRIXADI, MOUNJARO, BREZTRI, FARXIGA, VIVITROL, Korlym, GVOKE HYPOPEN, IBSRELA.
Industry payments across NJ — which companies pay providers there.
